Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
 | 2021 | Definition of minimal disease activity in psoriasis | Carretero, Gregorio; Carrascosa, J. M.; Puig, L.; Sánchez-Carazo, José L.; López-Ferrer, A.; Cueva, P.; Soria, C.; Rivera, R.; Belinchón, Isabel; The Psoriasis Group of the Spanish Academy of Dermatology, Venereology |  |
 | nov-2013 | Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry | Sánchez-Moya, Ana Isabel; García-Doval, I.; Carretero, G.; Sánchez-Carazo, J.; Ferrandiz, C.; Herrera Ceballos, E.; Alsina, M.; Ferrán, M.; López Estebaranz, José Luis; Gómez-García, F.; De la Cueva Dobao, P.; Carrascosa, J. M.; Vanaclocha, F.; Belinchón , Isabel ; Peral, F. |  |
 | 2015 | Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry | Carretero, G.; Ferrandiz, C.; Dauden, E.; Vanaclocha Sebastián, F.; Gómez-García, F. J.; Herrera Ceballos, E.; De la Cueva-Dobao, P.; Belinchón, Isabel; Sánchez-Carazo, J. L.; Alsina-Gibert, M.; López Estebaranz, José Luis; Ferrán, M.; Torrado, R.; Carrascosa, J. M.; Carazo, C. |  |
 | 2015 | Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry | Medina, C.; Carretero, G.; Ferrandiz, C.; Dauden, E.; Vanaclocha, F.; Gómez-García, F. J.; Herrera-Ceballos, E.; De la Cueva-Dobao, P.; Belinchón, Isabel; Sánchez-Carazo, J. L.; Alsina, M.; López Estebaranz, José Luis; Ferrán, M.; Carrascosa, J. M.; Torrado, R. |  |
 | 2016 | Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis | Dávila-Seijo, Paula; Dauden, E.; Carretero, G.; Ferrandiz, C.; Vanaclocha, F.; Gómez-García, F. J.; Herrera-Ceballos, E.; De la Cueva-Dobao, P.; Belinchón, Isabel; Sánchez-Carazo, J. L.; Alsina, M.; López Estebaranz, José Luis; Ferrán, M.; Torrado, R.; Carrascosa, J. M. |  |